Drug management of COPD.
作者信息
Burrill Peter D
出版信息
BMJ. 2007 Apr 28;334(7599):864. doi: 10.1136/bmj.39191.719352.3A.
Abstract
摘要
相似文献
1
Drug management of COPD.
BMJ. 2007 Apr 28;334(7599):864. doi: 10.1136/bmj.39191.719352.3A.
2
Use of beta-blockers in patients with COPD.
Ann Pharmacother. 2004 Jan;38(1):142-5. doi: 10.1345/aph.1D113.
3
[New beta2-agonists in asthma and COPD].
Pneumonol Alergol Pol. 2002;70 Suppl 1:58-61.
4
Comorbidities of chronic obstructive pulmonary disease.
Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S21-8. doi: 10.1097/01.mcp.0000410744.75216.d0.
5
Is the coprescription of beta blockers and beta2 agonists justified in COPD?
Thorax. 2008 Nov;63(11):1026; author reply 1026.
6
Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Epub 2008 Oct 28.
7
Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
J Am Coll Cardiol. 2004 Aug 4;44(3):497-502. doi: 10.1016/j.jacc.2004.03.063.
8
9
[Maintenance treatment of chronic obstructive pulmonary disease].
Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):826-8.
10
Use of beta blockers in patients with COPD.
Thorax. 2008 Apr;63(4):296-8. doi: 10.1136/thx.2007.091280.
本文引用的文献
1
Chronic obstructive pulmonary disease.
BMJ. 2007 Apr 14;334(7597):798. doi: 10.1136/bmj.39084.666736.94.
2
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
3
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Ann Intern Med. 2007 Apr 17;146(8):545-55. doi: 10.7326/0003-4819-146-8-200704170-00152. Epub 2007 Feb 19.
4
Health status measurement in chronic obstructive pulmonary disease.
Thorax. 2001 Nov;56(11):880-7. doi: 10.1136/thorax.56.11.880.
Zotero 插件